1-151683362-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001330723.2(SNX27):āc.1156G>Cā(p.Asp386His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,611,546 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.0013 ( 0 hom., cov: 31)
Exomes š: 0.0018 ( 4 hom. )
Consequence
SNX27
NM_001330723.2 missense
NM_001330723.2 missense
Scores
4
7
8
Clinical Significance
Conservation
PhyloP100: 8.95
Genes affected
SNX27 (HGNC:20073): (sorting nexin 27) This gene encodes a member of the sorting nexin family, a diverse group of cytoplasmic and membrane-associated proteins involved in endocytosis of plasma membrane receptors and protein trafficking through these compartments. All members of this protein family contain a phosphoinositide binding domain (PX domain). A highly similar protein in mouse is responsible for the specific recruitment of an isoform of serotonin 5-hydroxytryptamine 4 receptor into early endosomes, suggesting the analogous role for the human protein. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014138639).
BP6
Variant 1-151683362-G-C is Benign according to our data. Variant chr1-151683362-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 462804.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00127 (194/152238) while in subpopulation NFE AF= 0.00188 (128/68022). AF 95% confidence interval is 0.00162. There are 0 homozygotes in gnomad4. There are 86 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 194 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNX27 | NM_001330723.2 | c.1156G>C | p.Asp386His | missense_variant | 8/12 | ENST00000458013.7 | NP_001317652.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNX27 | ENST00000458013.7 | c.1156G>C | p.Asp386His | missense_variant | 8/12 | 5 | NM_001330723.2 | ENSP00000400333.2 |
Frequencies
GnomAD3 genomes AF: 0.00128 AC: 195AN: 152120Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
195
AN:
152120
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00163 AC: 405AN: 249160Hom.: 0 AF XY: 0.00160 AC XY: 215AN XY: 134720
GnomAD3 exomes
AF:
AC:
405
AN:
249160
Hom.:
AF XY:
AC XY:
215
AN XY:
134720
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00179 AC: 2615AN: 1459308Hom.: 4 Cov.: 30 AF XY: 0.00169 AC XY: 1229AN XY: 725978
GnomAD4 exome
AF:
AC:
2615
AN:
1459308
Hom.:
Cov.:
30
AF XY:
AC XY:
1229
AN XY:
725978
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00127 AC: 194AN: 152238Hom.: 0 Cov.: 31 AF XY: 0.00116 AC XY: 86AN XY: 74426
GnomAD4 genome
AF:
AC:
194
AN:
152238
Hom.:
Cov.:
31
AF XY:
AC XY:
86
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
9
ALSPAC
AF:
AC:
13
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
19
ExAC
AF:
AC:
247
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
SNX27-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 08, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Severe myoclonic epilepsy in infancy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;D;D
REVEL
Benign
Sift
Uncertain
.;D;D
Sift4G
Uncertain
.;D;D
Polyphen
1.0, 0.96
.;D;D
Vest4
0.74, 0.73
MVP
0.28
MPC
1.4
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at